Purchases and Sales Made in Q1 2024 in Pacira Bio Sciences, Inc. (PCRX)
This table provides information about the institutional ownership of Pacira Bio Sciences, Inc. (PCRX) during Q1 2024. The information is specifically focused on institutions that hold shares of Pacira BioSciences, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Nfj Investment Group, LLC
Dallas, TX |
SELL
|
- |
-13.6K- 11.65% |
$376K - $481K
|
103K
$2.38M
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-15K- 2.19% |
$416K - $532K
|
670K
$15.5M
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-15K- 2.19% |
$416K - $532K
|
670K
$15.5M
|
|
|
May 13, 2024
Q1 2024
|
Neumeier Poma Investment Counsel LLC
|
SELL
|
- |
-15.4K- 9.19% |
$425K - $545K
|
152K
$3.52M
|
|
|
May 10, 2024
Q1 2024
|
First National Bank Of Omaha
Omaha, NE |
SELL
|
- |
-16.4K- 62.92% |
$453K - $581K
|
9.65K
$224K
|
|
|
Apr 24, 2024
Q1 2024
|
Polaris Capital Management, LLC
Boston, MA |
SELL
|
- |
-16.4K- 74.55% |
$454K - $582K
|
5.6K
$130K
|
|
|
May 14, 2024
Q1 2024
|
Schroder Investment Management Group
London, X0 |
SELL
|
- |
-16.6K- 2.66% |
$459K - $587K
|
605K
$14M
|
|
|
May 14, 2024
Q1 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-17.5K- 3.32% |
$485K - $621K
|
511K
$11.8M
|
|
|
May 15, 2024
Q1 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-20K- 97.68% |
$555K - $711K
|
476
$11K
|
|
|
Jun 02, 2025
Q1 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-20.9K- 6.31% |
$578K - $740K
|
310K
$7.18M
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-25.3K- 29.72% |
$700K - $897K
|
59.8K
$1.39M
|
|
|
May 15, 2024
Q1 2024
|
Man Group PLC
London, X0 |
SELL
|
- |
-26.1K- 33.08% |
$723K - $926K
|
52.8K
$1.22M
|
|
|
May 15, 2024
Q1 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-32.5K- 1.68% |
$902K - $1.15M
|
1.9M
$44.1M
|
|
|
May 13, 2024
Q1 2024
|
Boston Partners
Boston, MA |
SELL
|
- |
-36.7K- 63.56% |
$1.02M - $1.3M
|
21.1K
$488K
|
|
|
Apr 24, 2024
Q1 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-50.3K- 20.41% |
$1.39M - $1.79M
|
196K
$4.55M
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-55.6K- 39.52% |
$1.54M - $1.97M
|
85.1K
$1.97M
|
|
|
May 01, 2024
Q1 2024
|
Baillie Gifford & CO
|
SELL
|
- |
-62.5K- 5.88% |
$1.73M - $2.22M
|
1M
$23.2M
|
|
|
May 15, 2024
Q1 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-71.7K- 17.77% |
$1.99M - $2.55M
|
332K
$7.69M
|
|
|
May 15, 2024
Q1 2024
|
Aqr Capital Management LLC
Greenwich, CT |
SELL
|
- |
-81.1K- 56.79% |
$2.25M - $2.88M
|
61.7K
$1.43M
|
|
|
May 13, 2024
Q1 2024
|
Premier Fund Managers LTD
|
SELL
|
- |
-118K- 94.56% |
$3.26M - $4.18M
|
6.77K
$157K
|
|
|
May 15, 2024
Q1 2024
|
Prosight Management, LP
Dallas, TX |
SELL
|
- |
-164K- 63.49% |
$4.54M - $5.82M
|
94.4K
$2.19M
|
|
|
May 08, 2024
Q1 2024
|
Russell Investments Group, Ltd.
|
SELL
|
- |
-166K- 73.47% |
$4.6M - $5.9M
|
60K
$1.39M
|
|
|
May 15, 2024
Q1 2024
|
Frontier Capital Management CO LLC
|
SELL
|
- |
-170K- 8.16% |
$4.71M - $6.04M
|
1.91M
$44.4M
|
|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-188K- 88.11% |
$5.21M - $6.67M
|
25.4K
$588K
|
|
|
May 15, 2024
Q1 2024
|
Clearline Capital LP
New York, NY |
SELL
|
- |
-194K- 58.69% |
$5.38M - $6.89M
|
137K
$3.17M
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-209K- 2.58% |
$5.79M - $7.42M
|
7.91M
$183M
|
|
|
May 14, 2024
Q1 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-281K- 74.66% |
$7.79M - $9.98M
|
95.5K
$2.21M
|
|
|
Sep 10, 2024
Q1 2024
|
Doma Perpetual Capital Management LLC
Miami, FL |
SELL
|
- |
-418K- 41.8% |
$11.6M - $14.8M
|
582K
$13.5M
|
|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-651K- 88.44% |
$18M - $23.1M
|
85.1K
$1.97M
|
|
|
May 13, 2024
Q1 2024
|
Vestal Point Capital, LP
New York, NY |
SELL
|
- |
-1.12M- 93.33% |
$31M - $39.7M
|
80K
$1.85M
|